Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Sabra Health Care REIT Inc (SBRA) A Good Stock To Buy?

Page 1 of 2

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn’t mean that they don’t have occasional colossal losses; they do (like Ackman’s recent Valeant losses). However, it is still good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards Sabra Health Care REIT Inc (NASDAQ:SBRA).

Sabra Health Care REIT Inc (NASDAQ:SBRA) shareholders have witnessed a decrease in hedge fund interest of late. What is quite surprising is that the hedge fund sentiment was similar to that of the market sentiment, as the shares of Sabra Health Care REIT Inc (NASDAQ:SBRA) lost 9.95% value during the quarter. In order to understand the hedge fund behavior, we will find out more about hedgies that had positions in Sabra Health Care REIT Inc (NASDAQ:SBRA), at the end of the last quarter.

At the end of this article we will also compare Sabra Health Care REIT Inc (NASDAQ:SBRA) to other stocks, including Compania de Minas Buenaventura SA (ADR) (NYSE:BVN), Nexstar Broadcasting Group, Inc. (NASDAQ:NXST), and Magellan Health Services Inc (NASDAQ:MGLN) to get a better sense of its popularity.

Follow Sabra Health Care Reit Inc. (NASDAQ:SBRA)
Trade (NASDAQ:SBRA) Now!

To most stock holders, hedge funds are assumed to be worthless, old financial tools of yesteryear. While there are over 8000 funds trading at the moment, we look at the top tier of this club, around 700 funds. These investment experts command bulk of all hedge funds’ total capital, and by watching their best investments, Insider Monkey has uncovered a number of investment strategies that have historically exceeded the market. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per year for a decade in their back tests.

With all of this in mind, let’s take a look at the latest action surrounding Sabra Health Care REIT Inc (NASDAQ:SBRA).

Hedge fund activity in Sabra Health Care REIT Inc (NASDAQ:SBRA)

At the end of the third quarter, a total of 8 of the hedge funds tracked by Insider Monkey were long this stock, a decrease of 33% from the previous quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were upping their holdings substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, J. Alan Reid, Jr.’s Forward Management has the biggest position in Sabra Health Care REIT Inc (NASDAQ:SBRA), worth close to $37.3 million, amounting to 3% of its total 13F portfolio. The second most bullish fund manager is Highland Capital Management, led by James Dondero, holding a $14.2 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Some other professional money managers that hold long positions comprise Israel Englander’s Millennium Management, Rod Hinze’s KeyPoint Capital Management, and Ken Griffin’s Citadel Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!